Beckinam Nowatzke, MSc, RAC, is a global life sciences executive with 25+ years leading quality, regulatory, and continuous improvement across pharma, biotech, and medical devices. Known for scaling quality systems, authoring FDA submissions, and building cultures of innovation, she is now seeking board and advisory opportunities with organizations driving medical innovation, patient access, and regulatory excellence.

Ross Bundy is a pioneering biotechnology leader driving innovation in biosensor technology and genome editing optimization. As the CEO of CRISPR QC and co-founder of Cardea Bio Inc., he has been instrumental in developing platforms that enable real-time biological insights through the "Internet of Biology." With expertise in business development, financial strategy, and operational management, Bundy has successfully scaled multiple companies and forged key industry partnerships. His visionary leadership and strategic execution continue to shape the future of biotechnology, advancing diagnostics, therapeutics, and bioinformatics with cutting-edge solutions.